Jagsonpal Pharmaceuticals Limited at its board meeting held on May 20, 2024, the Board recommended a dividend of INR 5 (100%) per equity share for the financial year ended March 31, 2024 subject to approval in AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
337 INR | +1.86% |
|
+0.06% | -13.33% |
May. 24 | Jagsonpal Launches Drug for Vasomotor Symptoms; Shares Jump 5% | MT |
May. 24 | Jagsonpal Launches Memup India's First Bioidentical Hormone Replacement Therapy in A Single Pill | CI |
1st Jan change | Capi. | |
---|---|---|
-13.33% | 105M | |
+58.87% | 827B | |
+38.56% | 634B | |
-7.10% | 350B | |
+13.66% | 319B | |
+6.50% | 294B | |
+12.68% | 240B | |
+14.48% | 221B | |
+0.04% | 219B | |
+7.49% | 167B |
- Stock Market
- Equities
- JAGSNPHARM Stock
- News Jagsonpal Pharmaceuticals Limited
- Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2024